UniProt ID | PHC2_HUMAN | |
---|---|---|
UniProt AC | Q8IXK0 | |
Protein Name | Polyhomeotic-like protein 2 | |
Gene Name | PHC2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 858 | |
Subcellular Localization | Nucleus . | |
Protein Description | Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility.. | |
Protein Sequence | MENELPVPHTSSSACATSSTSGASSSSGCNNSSSGGSGRPTGPQISVYSGIPDRQTVQVIQQALHRQPSTAAQYLQQMYAAQQQHLMLQTAALQQQHLSSAQLQSLAAVQQASLVSNRQGSTSGSNVSAQAPAQSSSINLAASPAAAQLLNRAQSVNSAAASGIAQQAVLLGNTSSPALTASQAQMYLRAQMLIFTPTATVATVQPELGTGSPARPPTPAQVQNLTLRTQQTPAAAASGPTPTQPVLPSLALKPTPGGSQPLPTPAQSRNTAQASPAGAKPGIADSVMEPHKKGDGNSSVPGSMEGRAGLSRTVPAVAAHPLIAPAYAQLQPHQLLPQPSSKHLQPQFVIQQQPQPQQQQPPPQQSRPVLQAEPHPQLASVSPSVALQPSSEAHAMPLGPVTPALPLQCPTANLHKPGGSQQCHPPTPDTGPQNGHPEGVPHTPQRRFQHTSAVILQLQPASPPQQCVPDDWKEVAPGEKSVPETRSGPSPHQQAIVTAMPGGLPVPTSPNIQPSPAHETGQGIVHALTDLSSPGMTSGNGNSASSIAGTAPQNGENKPPQAIVKPQILTHVIEGFVIQEGAEPFPVGRSSLLVGNLKKKYAQGFLPEKLPQQDHTTTTDSEMEEPYLQESKEEGAPLKLKCELCGRVDFAYKFKRSKRFCSMACAKRYNVGCTKRVGLFHSDRSKLQKAGAATHNRRRASKASLPPLTKDTKKQPTGTVPLSVTAALQLTHSQEDSSRCSDNSSYEEPLSPISASSSTSRRRQGQRDLELPDMHMRDLVGMGHHFLPSEPTKWNVEDVYEFIRSLPGCQEIAEEFRAQEIDGQALLLLKEDHLMSAMNIKLGPALKIYARISMLKDS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
97 (in isoform 3) | Ubiquitination | - | 24.28 | 21906983 | |
97 (in isoform 2) | Ubiquitination | - | 24.28 | 21906983 | |
155 | Phosphorylation | QLLNRAQSVNSAAAS HHHHHHHHHHHHHHH | 23.45 | 22210691 | |
158 | Phosphorylation | NRAQSVNSAAASGIA HHHHHHHHHHHHCHH | 19.68 | 22210691 | |
174 | Phosphorylation | QAVLLGNTSSPALTA HHHHHCCCCCCCCCH | 28.87 | 20068231 | |
180 | Phosphorylation | NTSSPALTASQAQMY CCCCCCCCHHHHHHH | 26.77 | 22210691 | |
226 | Phosphorylation | PAQVQNLTLRTQQTP HHHHCEEEEEECCCC | 23.03 | 24719451 | |
258 (in isoform 3) | Ubiquitination | - | 25.06 | 21906983 | |
258 (in isoform 2) | Ubiquitination | - | 25.06 | 21906983 | |
271 | Phosphorylation | TPAQSRNTAQASPAG CCCCCCCCCCCCCCC | 21.02 | 25002506 | |
275 | Phosphorylation | SRNTAQASPAGAKPG CCCCCCCCCCCCCCC | 11.82 | 22617229 | |
286 | Phosphorylation | AKPGIADSVMEPHKK CCCCCCCCCCCCCCC | 17.84 | 25002506 | |
295 (in isoform 2) | Ubiquitination | - | 63.08 | - | |
298 | Phosphorylation | HKKGDGNSSVPGSME CCCCCCCCCCCCCCC | 37.94 | 30631047 | |
303 | Phosphorylation | GNSSVPGSMEGRAGL CCCCCCCCCCCCCCC | 13.95 | 24425749 | |
311 | Phosphorylation | MEGRAGLSRTVPAVA CCCCCCCCCCCCHHH | 25.61 | 30631047 | |
462 (in isoform 5) | Phosphorylation | - | 43.74 | 28188228 | |
590 | Phosphorylation | EPFPVGRSSLLVGNL CCCCCCCCCEEHHHH | 21.29 | 30266825 | |
591 | Phosphorylation | PFPVGRSSLLVGNLK CCCCCCCCEEHHHHH | 25.10 | 30266825 | |
598 | Sumoylation | SLLVGNLKKKYAQGF CEEHHHHHHHHHCCC | 51.74 | 28112733 | |
598 | 2-Hydroxyisobutyrylation | SLLVGNLKKKYAQGF CEEHHHHHHHHHCCC | 51.74 | - | |
600 | Sumoylation | LVGNLKKKYAQGFLP EHHHHHHHHHCCCCC | 44.20 | 28112733 | |
601 | Phosphorylation | VGNLKKKYAQGFLPE HHHHHHHHHCCCCCC | 17.03 | 23403867 | |
603 (in isoform 4) | Ubiquitination | - | 39.83 | 21906983 | |
616 | Phosphorylation | KLPQQDHTTTTDSEM CCCCCCCCCCCCHHH | 33.84 | 30266825 | |
617 | Phosphorylation | LPQQDHTTTTDSEME CCCCCCCCCCCHHHC | 25.03 | 30266825 | |
618 | Phosphorylation | PQQDHTTTTDSEMEE CCCCCCCCCCHHHCC | 29.75 | 30266825 | |
619 | Phosphorylation | QQDHTTTTDSEMEEP CCCCCCCCCHHHCCC | 35.12 | 23927012 | |
621 | Phosphorylation | DHTTTTDSEMEEPYL CCCCCCCHHHCCCHH | 36.43 | 30266825 | |
627 | Phosphorylation | DSEMEEPYLQESKEE CHHHCCCHHHHCHHC | 25.05 | 30266825 | |
631 | Phosphorylation | EEPYLQESKEEGAPL CCCHHHHCHHCCCCC | 32.19 | 23403867 | |
632 | Ubiquitination | EPYLQESKEEGAPLK CCHHHHCHHCCCCCE | 60.06 | 21906983 | |
632 | Sumoylation | EPYLQESKEEGAPLK CCHHHHCHHCCCCCE | 60.06 | 28112733 | |
633 (in isoform 1) | Ubiquitination | - | 71.58 | 21906983 | |
641 | Sumoylation | EGAPLKLKCELCGRV CCCCCEEEEEECCCC | 24.87 | - | |
641 | Sumoylation | EGAPLKLKCELCGRV CCCCCEEEEEECCCC | 24.87 | - | |
653 | Acetylation | GRVDFAYKFKRSKRF CCCEEEECCCCHHCC | 40.77 | 23236377 | |
655 | Ubiquitination | VDFAYKFKRSKRFCS CEEEECCCCHHCCCH | 52.16 | - | |
662 | Phosphorylation | KRSKRFCSMACAKRY CCHHCCCHHHHHHHH | 13.50 | 28857561 | |
667 | Acetylation | FCSMACAKRYNVGCT CCHHHHHHHHCCCCC | 56.13 | 25953088 | |
667 | Ubiquitination | FCSMACAKRYNVGCT CCHHHHHHHHCCCCC | 56.13 | - | |
669 | Phosphorylation | SMACAKRYNVGCTKR HHHHHHHHCCCCCCC | 17.31 | 29759185 | |
675 | 2-Hydroxyisobutyrylation | RYNVGCTKRVGLFHS HHCCCCCCCEECCCC | 49.52 | - | |
675 | Acetylation | RYNVGCTKRVGLFHS HHCCCCCCCEECCCC | 49.52 | 30591265 | |
682 | Phosphorylation | KRVGLFHSDRSKLQK CCEECCCCCHHHHHH | 27.64 | 25159151 | |
685 | Phosphorylation | GLFHSDRSKLQKAGA ECCCCCHHHHHHHCH | 42.58 | 28555341 | |
701 | Phosphorylation | THNRRRASKASLPPL HHHHHHHHHCCCCCC | 27.26 | 26055452 | |
702 | Sumoylation | HNRRRASKASLPPLT HHHHHHHHCCCCCCC | 40.80 | 28112733 | |
704 | Phosphorylation | RRRASKASLPPLTKD HHHHHHCCCCCCCCC | 45.18 | 25159151 | |
709 | Phosphorylation | KASLPPLTKDTKKQP HCCCCCCCCCCCCCC | 32.42 | 20873877 | |
710 | Ubiquitination | ASLPPLTKDTKKQPT CCCCCCCCCCCCCCC | 71.70 | - | |
712 | Phosphorylation | LPPLTKDTKKQPTGT CCCCCCCCCCCCCCC | 41.52 | 20068231 | |
717 | Phosphorylation | KDTKKQPTGTVPLSV CCCCCCCCCCCCEEH | 42.88 | 29978859 | |
719 | Phosphorylation | TKKQPTGTVPLSVTA CCCCCCCCCCEEHHE | 22.79 | 29978859 | |
723 | Phosphorylation | PTGTVPLSVTAALQL CCCCCCEEHHEHHHH | 16.02 | 26657352 | |
725 | Phosphorylation | GTVPLSVTAALQLTH CCCCEEHHEHHHHHC | 11.66 | 29978859 | |
731 | Phosphorylation | VTAALQLTHSQEDSS HHEHHHHHCCCCCHH | 13.40 | 28450419 | |
733 | Phosphorylation | AALQLTHSQEDSSRC EHHHHHCCCCCHHCC | 29.99 | 17525332 | |
737 | Phosphorylation | LTHSQEDSSRCSDNS HHCCCCCHHCCCCCC | 20.94 | 28450419 | |
738 | Phosphorylation | THSQEDSSRCSDNSS HCCCCCHHCCCCCCC | 50.02 | 28450419 | |
741 | Phosphorylation | QEDSSRCSDNSSYEE CCCHHCCCCCCCCCC | 38.42 | 29396449 | |
744 | Phosphorylation | SSRCSDNSSYEEPLS HHCCCCCCCCCCCCC | 39.01 | 29396449 | |
745 | Phosphorylation | SRCSDNSSYEEPLSP HCCCCCCCCCCCCCC | 42.70 | 28102081 | |
746 | Phosphorylation | RCSDNSSYEEPLSPI CCCCCCCCCCCCCCC | 24.92 | 30108239 | |
751 | Phosphorylation | SSYEEPLSPISASSS CCCCCCCCCCCCCHH | 30.79 | 28102081 | |
754 | Phosphorylation | EEPLSPISASSSTSR CCCCCCCCCCHHHHH | 26.03 | 30108239 | |
756 | Phosphorylation | PLSPISASSSTSRRR CCCCCCCCHHHHHHH | 20.31 | 30108239 | |
757 | Phosphorylation | LSPISASSSTSRRRQ CCCCCCCHHHHHHHH | 37.03 | 30108239 | |
758 | Phosphorylation | SPISASSSTSRRRQG CCCCCCHHHHHHHHC | 28.10 | 30108239 | |
759 | Phosphorylation | PISASSSTSRRRQGQ CCCCCHHHHHHHHCC | 28.35 | 29978859 | |
760 | Phosphorylation | ISASSSTSRRRQGQR CCCCHHHHHHHHCCC | 26.24 | 20068231 | |
764 (in isoform 4) | Ubiquitination | - | 51.03 | 21906983 | |
793 | Ubiquitination | FLPSEPTKWNVEDVY CCCCCCCCCCHHHHH | 47.70 | 2190698 | |
794 (in isoform 1) | Ubiquitination | - | 19.31 | 21906983 | |
801 (in isoform 5) | Phosphorylation | - | 34.15 | 27642862 | |
841 | Sumoylation | LMSAMNIKLGPALKI HHHHHCCCHHHHHHH | 42.24 | - | |
841 | Sumoylation | LMSAMNIKLGPALKI HHHHHCCCHHHHHHH | 42.24 | - | |
847 | Sumoylation | IKLGPALKIYARISM CCHHHHHHHHHHHHH | 35.46 | 28112733 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PHC2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PHC2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PHC2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-621, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-733, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-701 AND SER-704, ANDMASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-745, AND MASSSPECTROMETRY. |